OPCH · Option Care Health, Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Feb 3, 2020; bars on opposite sides are not compared.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 117.48M | Three Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income $53.91M
+$14.02M Interest expense, net
+$20.07M Income tax expense
+$18.38M Depreciation and amortization expense
+$8.38M Stock-based incentive compensation expense
+$2.71M Restructuring, acquisition, integration and other
= Adjusted EBITDA $117.48M
|
|||
| Adjusted earnings per share, diluted non-GAAP | $0.4 | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OPCH
this stock
Option Care Health, Inc.
|
$3.76B | -24.5% | +16.2% | 18.7 | 7.7% |
|
HCA
HCA Healthcare, Inc.
|
$95.12B | -8.5% | +7.1% | 14.8 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.21B | -5.9% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.08B | +38.0% | +0.9% | 10.6 | 3.1% |
|
FMS
Fresenius Medical Care AG
|
$12.38B | -1.8% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Feb 3, 2020; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OPCH | +3.0% | +0.5% | -21.1% | +4.4% | -24.5% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +3.4% | -4.6% | -33.5% | +1.8% | -36.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.